Bank Of New York Mellon Corp Applied Molecular Transport Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $198,700 - $550,746	-71,993 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$5.63 - $13.88 $168 - $416	30 Added 0.04%	71,993 $541,000
Q4 2021 Feb 11, 2022	BUY	$13.23 - $26.05 $20,652 - $40,664	1,561 Added 2.22%	71,963 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$25.87 - $46.61 $160,549 - $289,261	6,206 Added 9.67%	70,402 $1.82 Million
Q2 2021 Aug 11, 2021	SELL	$39.76 - $64.31 $104,370 - $168,813	-2,625 Reduced 3.93%	64,196 $2.94 Million

Q1 2021 May 13, 2021	BUY	$30.5 - $74.14 $570,533 - $1.39 Million	18,706 Added 38.88%	66,821 $2.94 Million
Q4 2020 Feb 09, 2021	BUY	$29.39 - $35.0 $470,945 - $560,840	16,024 Added 49.93%	48,115 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$20.49 - $33.58 $657,544 - $1.08 Million	32,091 New	32,091 $1.02 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.